Adrian Ebner News Today

June 8, 2023—Obvius Robotics, Inc. announced the completion of the first-in-human (FIH) cases with the company’s Certa percutaneous access

WESTON, Fla: Obvius Robotics, Inc., a medical device company that has developed an innovative technology platform for performing percutaneous access, today announced the successful completion of its first human cases.

Obvius Robotics announced today that it successfully completed the first human cases with its Certa Access System.

Mission Viejo, California, United States, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Leonhardt Ventures, LLC  is pleased to announce the United States Patent and...

Three leading U.S. interventional cardiologists attend initial cases as company prepares to expand its clinical program 

 Three leading U.S. interventional cardiologists attend initial cases as company prepares to expand its clinical programLOS GATOS, Calif., Sept. 1...

Supira Medical announced today that it initiated the first-in-human clinical study of its percutaneous ventricular assist device (pVAD).

This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America,...

Artio Medical Announces Successful First Human Use of the Amplifi™ Vein Dilation System First-of-its-kind medical device aims to improve vascular access for hemodialysis patients News provided by Share this article Share this article PRAIRIE VILLAGE, Kan., Jan. 27, 2021 /PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today that it has successfully completed the firs...

Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Two CoreoGraft Patients Have Reached 30 Day Milestone IRVINE, CA / ACCESSWIRE / December 16, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that two patients who have undergone heart bypass surgeries utilizing HJLIs CoreoGraft have reached the 30-day milestone and are reported to have good cardiac function. The first two CoreoGraft surgeries w...